Sponsor or institution
Clinical trials and research at Third Element Bio INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $897,804 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Isoform-based brain therapies for Alzheimer’s disease
A patient-facing look at how researchers aim to precisely target brain RNA variants to help people with Alzheimer's disease and related dementias.
-
RUNX1-based therapy to slow memory decline in Alzheimer's disease
A small Phase I project is testing a RUNX1-targeting treatment to slow cognitive decline in people with Alzheimer's disease.
-
Finding a way to slow cognitive decline in Alzheimer's disease using a new treatment approach.
This study is looking at a new treatment that could help improve brain function and slow down memory loss in people with Alzheimer's by targeting a specific factor in the brain, and they're testing it in mice to see if it works.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.